HWPC(SH:688799) Xin Lang Cai Jing·2025-10-15 02:40Core Viewpoint - Warner Pharmaceutical's stock increased by 5.06% to 61.43 CNY per share, with a total market capitalization of 8.067 billion CNY as of October 15 [1] Company Overview - Warner Pharmaceutical, established on April 30, 2001, is located in Changsha, Hunan Province, and was listed on July 13, 2021 [1] - The company's main business includes the research, production, and sales of chemical raw materials, chemical drug formulations, and traditional Chinese medicine formulations [1] - Revenue composition: 73.19% from formulations, 25.22% from raw materials and intermediates, 1.52% from technical services, 0.06% from plant extracts and food, and 0.01% from other sources [1] Shareholder Information - In the second quarter, Invesco Great Wall Fund's "Invesco Great Wall Research Selected Stocks A" (000688) entered the top ten circulating shareholders of Warner Pharmaceutical, holding 1.2882 million shares, which is 0.98% of the circulating shares [2] - The fund has achieved a year-to-date return of 45.98% and a one-year return of 54.96%, ranking 463 out of 4220 and 372 out of 3857 in its category, respectively [2] Fund Manager Profile - The fund manager of Invesco Great Wall Research Selected Stocks A is Jiang Shan, who has been in the position for 4 years and 65 days [3] - The total asset size of the fund is 10.811 billion CNY, with the best return during Jiang's tenure being 181.78% and the worst being -16.09% [3]